BridgeMD
Compares treatment options for White Spot Lesion
Official title Resin Infiltration Vs Self-Assembling Peptide (P11-4) in Treating White Spot Lesions
ClinicalTrials.gov ID: NCT06708481
What this study is testing
What is P11-4, a self-assembling peptide?
P11-4, a self-assembling peptide is an investigational medicine, being studied as a potential treatment for white spot lesion.
Also referred to as Curodont- repair.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Clinical assessment of the effectiveness of two treatment modalities (self-assembling peptide (P11-4) (alone or combined with fluoride) and resin infiltration) for treating white spot lesions
- Phase 1: an early, usually small safety study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 7 to 14. Healthy volunteers may be eligible.
You may be able to join if
- Age (a range from 7-14 years of age was determined)
- Good general health (absence of disease/no handicaps, to ensure oral care at home)
- Preserved pulp vitality of the teeth.
- Consolidated oral care daily.
- Agreement by patient and parents (or guardians) to participate in the study
You likely can't join if
- Patients with periodontal diseases (periodontal pockets or dental mobility) or radiologically identified pathologies (periapical radiolucency).
- Teeth revealing any restorations were excluded from the current study.
- Any previous or planned WSL treatment.
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Giza Governorate, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 7 years to 14 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Giza Governorate, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.